HFA Premium Access

Mid-regional pro-atrial natriuretic peptide predicts unfavorable clinical course in heart failure patients undergoing cardiac resynchronization therapy

Topic: Cardiac resynchronisation therapy

Congress Presentation

About the speaker

Doctor Mattia Arrigo

Stadtspital Zurich, Zurich (Switzerland)
5 presentations
0 follower

14 more presentations in this session

Clinical significance of tricuspid regurgitation severity in heart failure

Speaker: Associate Professor D. Aronson (Haifa, IL)


A simple score to discriminate pulmonary hypertension due to HFpEF

Speaker: Doctor E. Berthelot (Le Kremlin-Bicetre, FR)


Diabetes is associated with long-term adverse clinical outcomes in a multinational cohort of ambulatory patients with chronic heart failure. Results from the ESC-HFA Long-Term Heart Failure Registry.

Speaker: Doctor M. Dauriz (Verona, IT)


In anaemic heart failure patients abnormal erythropoietin is related to disease severity and renal impairment, but neither inflammation nor iron deficiency

Speaker: Mr M. Tkaczyszyn (Wroclaw, PL)


Right ventricular dyssynchrony and excercise capacity in idiopathic pulmonary arterial hypertension


Access the full session

Rapid Fire 5 - Comorbidities

Speakers: Doctor M. Arrigo, Associate Professor D. Aronson, Doctor E. Berthelot, Doctor M. Dauriz, Mr M. Tkaczyszyn

About the event



21 May - 24 May 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb